GW Pharmaceuticals Plc

( )
GWPH PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
HZNPHorizon Therapeutics Plc 0.02%55.246.5%$161.03m
CTLTCatalent, Inc. -0.87%72.742.1%$123.61m
VRXValeant Pharmaceuticals International, Inc. -0.43%18.3414.1%$107.92m
JAZZJazz Pharmaceuticals Plc 0.13%109.752.4%$107.59m
BHCBausch Health Cos., Inc. -0.43%18.340.0%$80.79m
UTHRUnited Therapeutics Corp. -0.55%120.3314.3%$73.55m
ICPTIntercept Pharmaceuticals, Inc. 1.23%47.0916.8%$59.37m
AXSMAxsome Therapeutics, Inc. -3.50%80.971.9%$52.04m
ZGNXZogenix, Inc. 0.41%29.197.5%$49.03m
PRGOPerrigo Co. Plc 0.64%55.186.8%$48.99m
MYOKMyoKardia, Inc. 0.29%94.112.1%$45.92m
AMRNAmarin Corp. Plc -1.57%6.921.6%$43.52m
ARGXargenx SE 0.38%228.720.0%$41.63m
PCRXPacira Biosciences, Inc. -1.45%52.3710.3%$40.42m
ICLRICON plc -0.55%166.914.3%$38.32m

Company Profile

GW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It offers its cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.